PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+9.01%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$2.7B
AUM Growth
+$129M
(+5%)
Cap. Flow
-$25.7M
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
38.9%
Holding
1,194
New
46
Increased
298
Reduced
730
Closed
120
Top Buys
| 1 |
NVIDIA
NVDA
|
+$45.9M |
| 2 |
Broadcom
AVGO
|
+$4.33M |
| 3 |
Booking.com
BKNG
|
+$3.04M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$2.71M |
| 5 |
NextEra Energy, Inc.
NEE
|
+$2.61M |
Top Sells
| 1 |
Apple
AAPL
|
+$25.3M |
| 2 |
Amazon
AMZN
|
+$6.38M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$3.01M |
| 4 |
ConocoPhillips
COP
|
+$2.87M |
| 5 |
Novavax
NVAX
|
+$2.63M |
Sector Composition
| 1 | Technology | 47.26% |
| 2 | Healthcare | 11.3% |
| 3 | Consumer Discretionary | 9.84% |
| 4 | Communication Services | 9.16% |
| 5 | Financials | 4.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Humana
HUM
$32.9B
| $684K | 0.03% |
1,830
-39
| -2% | -$14.6K |
|
402
Syndax Pharmaceuticals
SNDX
$1.36B
| $682K | 0.03% |
33,231
-25,016
| -43% | -$514K |
|
403
Denali Therapeutics
DNLI
$2.14B
| $682K | 0.03% |
29,373
-39,101
| -57% | -$908K |
|
|
ONC
404
BeOne Medicines Ltd. American Depositary Shares
ONC
$34.5B
| $682K | 0.03% |
4,780
-1,181
| -20% | -$168K |
|
405
Sanofi
SNY
$115B
| $680K | 0.03% |
14,007
+406
| +3% | +$19.7K |
|
406
HSBC
HSBC
$237B
| $677K | 0.03% |
15,564
-3,137
| -17% | -$136K |
|
407
Cirrus Logic
CRUS
$5.78B
| $673K | 0.03% |
5,271
+103
| +2% | +$13.1K |
|
408
Evergy
EVRG
$16.5B
| $672K | 0.02% |
12,695
+4,121
| +48% | +$218K |
|
409
Aflac
AFL
$57.3B
| $672K | 0.02% |
7,522
-316
| -4% | -$28.2K |
|
410
L3Harris
LHX
$51.6B
| $669K | 0.02% |
2,977
-41
| -1% | -$9.21K |
|
411
Transocean
RIG
$3.06B
| $666K | 0.02% |
124,486
+20,054
| +19% | +$107K |
|
412
Viatris
VTRS
$11.9B
| $665K | 0.02% |
62,591
-5,423
| -8% | -$57.6K |
|
413
Crown Castle
CCI
$40.9B
| $657K | 0.02% |
6,729
+188
| +3% | +$18.4K |
|
414
Vericel Corp
VCEL
$1.58B
| $657K | 0.02% |
14,311
-14,534
| -50% | -$667K |
|
415
W.W. Grainger
GWW
$47.5B
| $649K | 0.02% |
719
-18
| -2% | -$16.2K |
|
416
Republic Services
RSG
$71.3B
| $647K | 0.02% |
3,327
-43
| -1% | -$8.36K |
|
417
Bilibili
BILI
$10.2B
| $645K | 0.02% |
41,806
+2,257
| +6% | +$34.8K |
|
418
RELX
RELX
$82.4B
| $643K | 0.02% |
14,007
+407
| +3% | +$18.7K |
|
419
Ameriprise Financial
AMP
$46.4B
| $640K | 0.02% |
1,497
-46
| -3% | -$19.7K |
|
420
BP
BP
$89.5B
| $639K | 0.02% |
17,704
+514
| +3% | +$18.6K |
|
421
America Movil
AMX
$59.6B
| $638K | 0.02% |
37,515
+630
| +2% | +$10.7K |
|
422
Agios Pharmaceuticals
AGIO
$2.07B
| $637K | 0.02% |
14,773
-19,941
| -57% | -$860K |
|
423
AB InBev
BUD
$115B
| $633K | 0.02% |
10,892
+313
| +3% | +$18.2K |
|
424
Otis Worldwide
OTIS
$34.4B
| $626K | 0.02% |
6,500
-110
| -2% | -$10.6K |
|
425
Dr. Reddy's Laboratories
RDY
$12.1B
| $625K | 0.02% |
40,990
+2,225
| +6% | +$33.9K |
|